Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rapid Bio Tests was a small U.S. diagnostics company focused on developing rapid diagnostic test platforms that could be used in the field or office without instrumentation or electricity. Company disclosures indicated completed R&D on rapid field tests for Hepatitis B virus and bubonic plague, with additional tests under development for mad cow disease, rabies virus, and West Nile virus. The business model centered on acquiring rights to a portfolio of rapid diagnostic tests and developing and manufacturing an array of simple, fast point-of-care assays. The company later shifted away from this business and changed its name to Bio-Warm, indicating that Rapid Bio Tests no longer operated as an active standalone diagnostics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rapid Bio Tests.